NovaBridge Biosciences (NBP) insider trading.
In Q3 2026, insiders at NovaBridge Biosciences reported 10 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 4 sales worth $92K.
- Transactions
- 10
- Purchases (P)
- 0
- Sales (S)
- 4
- Net shares, P minus S
- -123,954
- Insiders
- 4
- Last filed
- 2026-09-21
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Xu Cong Claire | Officer · EVP, Clinical Development | 4 | 0 | 2 |
| Cao Sean Wuxiong | Officer · Chief Bus. Development Officer | 3 | 0 | 1 |
| Dennis Phillip Andrew | Officer · Chief Medical Officer | 2 | 0 | 1 |
| Lenz Robert A. | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-18 | Dennis Phillip Andrew | S (D) | 8,209 | $0.71 | 173,427 | Form 4 |
| 2026-09-17 | Dennis Phillip Andrew | M (A) | 23,695 | — | 181,636 | Form 4 |
| 2026-09-09 | Cao Sean Wuxiong | S (D) | 107,978 | $0.74 | 266,467 | Form 4 |
| 2026-09-03 | Cao Sean Wuxiong | M (A) | 104,236 | — | 374,445 | Form 4 |
| 2026-09-03 | Cao Sean Wuxiong | M (A) | 235,136 | — | 270,209 | Form 4 |
| 2026-08-31 | Xu Cong Claire | S (D) | 3,282 | $0.79 | 304,201 | Form 4 |
| 2026-08-30 | Xu Cong Claire | M (A) | 9,382 | — | 307,483 | Form 4 |
| 2026-08-22 | Lenz Robert A. | M (A) | 17,218 | — | 17,218 | Form 4 |
| 2026-07-06 | Xu Cong Claire | S (D) | 4,485 | $0.89 | 298,101 | Form 4 |
| 2026-07-04 | Xu Cong Claire | M (A) | 12,432 | — | 302,586 | Form 4 |
Transaction codes in this quarter
Get NBP insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1778016&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · NBP company page · NovaBridge Biosciences on SEC.gov
Questions
Are insiders buying or selling NovaBridge Biosciences (NBP)?
In Q3 2026, insiders at NovaBridge Biosciences reported 10 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 4 sales worth $92K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these NovaBridge Biosciences insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/nbp.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.